[go: up one dir, main page]

ZA851642B - A pharmaceutical formulation containing azapropazone - Google Patents

A pharmaceutical formulation containing azapropazone

Info

Publication number
ZA851642B
ZA851642B ZA851642A ZA851642A ZA851642B ZA 851642 B ZA851642 B ZA 851642B ZA 851642 A ZA851642 A ZA 851642A ZA 851642 A ZA851642 A ZA 851642A ZA 851642 B ZA851642 B ZA 851642B
Authority
ZA
South Africa
Prior art keywords
azapropazone
pharmaceutical formulation
formulation containing
carboxylate
molar ratio
Prior art date
Application number
ZA851642A
Other languages
English (en)
Inventor
Kim Drummond Rainsford
Michael Wellesley Whitehouse
Original Assignee
Kim Drummond Rainsford
Whitehouse Michael W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Drummond Rainsford, Whitehouse Michael W filed Critical Kim Drummond Rainsford
Publication of ZA851642B publication Critical patent/ZA851642B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA851642A 1984-03-08 1985-03-05 A pharmaceutical formulation containing azapropazone ZA851642B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08406055A GB2155329A (en) 1984-03-08 1984-03-08 A pharmaceutical formulation containing azapropazone

Publications (1)

Publication Number Publication Date
ZA851642B true ZA851642B (en) 1985-10-30

Family

ID=10557766

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA851642A ZA851642B (en) 1984-03-08 1985-03-05 A pharmaceutical formulation containing azapropazone

Country Status (15)

Country Link
US (1) US5034379A (fr)
EP (1) EP0154523B1 (fr)
JP (1) JPS60215635A (fr)
AT (1) ATE41603T1 (fr)
AU (1) AU572968B2 (fr)
CA (1) CA1256803A (fr)
DE (1) DE3568943D1 (fr)
DK (1) DK106485A (fr)
ES (1) ES8800598A1 (fr)
GB (1) GB2155329A (fr)
NO (1) NO850913L (fr)
NZ (1) NZ211294A (fr)
PH (1) PH21053A (fr)
PT (1) PT80078B (fr)
ZA (1) ZA851642B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668676A (en) * 1985-12-06 1987-05-26 E.I. Du Pont De Nemours And Company Azapropazone prevention of post-ischemic tissue damage
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
EP0278997A1 (fr) * 1987-02-17 1988-08-24 Siegfried Aktiengesellschaft Capsules rectales d'azapropazone
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
CA2132427A1 (fr) * 1992-03-19 1993-09-30 Albert F. Burton Methode et composition pour supprimer les effets secondaires des medicaments anti-inflammatoires
AU4055993A (en) * 1992-05-15 1993-12-13 University Of British Columbia, The N-acetyl glucosamine as gastroprotective agent
GB9321655D0 (en) * 1993-10-20 1993-12-08 Glyzinc Pharma Ltd Pharmaceutical formulation of aspirin and salicylates
FR2836656B1 (fr) * 2002-03-01 2004-05-28 Michelin Soc Tech Dispositif et procede de traitement des phenomenes de perte de pression et de roulage a plat des pneumatiques d'un vehicule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU511852B2 (en) * 1977-11-09 1980-09-11 Australian National University, The Formulating aspirin andthe like
EP0013783B1 (fr) * 1979-01-12 1984-04-04 The Australian National University Protection de la muqueuse gastrique contre une lésion par de l'aspirine ou par un médicament apparenté
EP0028660B1 (fr) * 1979-11-10 1985-10-23 Siegfried Aktiengesellschaft Inhibiteurs de la xanthine oxydase et application des dérivés de la benzotriazine

Also Published As

Publication number Publication date
CA1256803A (fr) 1989-07-04
NZ211294A (en) 1987-09-30
US5034379A (en) 1991-07-23
JPS60215635A (ja) 1985-10-29
DE3568943D1 (en) 1989-04-27
DK106485D0 (da) 1985-03-08
GB8406055D0 (en) 1984-04-11
PT80078A (en) 1985-04-01
EP0154523A3 (en) 1986-06-04
EP0154523A2 (fr) 1985-09-11
AU572968B2 (en) 1988-05-19
ATE41603T1 (de) 1989-04-15
PT80078B (en) 1987-02-23
EP0154523B1 (fr) 1989-03-22
ES541054A0 (es) 1987-11-16
ES8800598A1 (es) 1987-11-16
DK106485A (da) 1985-09-09
GB2155329A (en) 1985-09-25
NO850913L (no) 1985-09-09
PH21053A (en) 1987-07-03
AU3950685A (en) 1985-09-12

Similar Documents

Publication Publication Date Title
EP0276501A3 (en) Thickening compositions and thickened aqueous acid solutions
ES8706443A1 (es) Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa)
AU5226796A (en) Water insoluble derivatives of polyanionic polysaccharides
DE3662402D1 (en) Bleach compositions
EP0259939A3 (en) Aqueous polysaccharide compositions
GB1463966A (en) Depilatory formulation
PL340580A1 (en) Dibenzylidene sorbitol containing antiperspirant
ES2062161T3 (es) Forma liquida estable de acido 5-aminosalicilico.
NZ214305A (en) Inhibiting the precipitation and deposition of alkaline earth metal scales in aqueous systems using an anionic polyelectrolyte and an anionic surfactant
GB1232720A (fr)
DE3568943D1 (en) A pharmaceutical formulation containing azapropazone
IL75598A (en) Stabilized aqueous solutions of 5-chloro-3-isothiazolones,their preparation and their use
IE822795L (en) Fluoride ion-containing dentifrices
EP0303187A3 (en) Aqueous preparations of ionic surfactants with an increased viscosity
EP0233774A3 (en) Carboxylated surfactant containing lubricants, production and use
IE780076L (en) Antimicrobial compositions
GB9019875D0 (en) Pharmaceutical compositions
ES2061829T3 (es) Solucion acuosa, estable frente al almacenamiento, de alquiltrialcoxisilanos.
YU26790A (en) Pentamidine solutions
GB1394764A (en) 2,5-hexanedione
GB8514315D0 (en) Preparation of aqueous solution
ZA878354B (en) Stabilization of aqueous alkali metal aluminate solutions
CA2026575A1 (fr) Solutions stables de tetraphenylborate de sodium
EP0437621A4 (en) Aqueous solution of motilin
SE7613849L (sv) For injicering ferdigstellda losningar